MiRagen Therapeutics Garners $20,000,000 Series B Funding Round

  • Feed Type
  • Date
    4/24/2012
  • Company Name
    MiRagen Therapeutics
  • Mailing Address
    6200 Lookout Rd Boulder, CO 80301
  • Company Description
    Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
  • Website
    http://www.miragentherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funding enables miRagen to advance the development of its compelling microRNA-based therapeutics pipeline.
  • M&A Terms
  • Venture Investor
    Remeditex Ventures
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Boulder Ventures
  • Venture Investor
    Amgen Ventures
  • Venture Investor
    Broadview Ventures

Trending on Xconomy